Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L6 pseudogene 28 (RPL6P28)** is a *pseudogene* in the human genome, meaning it resembles a functional gene (in this case, the ribosomal protein L6 gene, RPL6) but is **non-functional** and does not produce a functional protein[3][4]. Pseudogenes such as RPL6P28 are numerous for ribosomal protein genes and occur as processed copies throughout the genome[3][6]. RPL6P28 should not be confused with the true protein-coding gene **RPL6**, which encodes a component of the 60S ribosomal subunit involved in protein synthesis[5][6][8]. As RPL6P28 is non-coding and does not have a biological function, drug interactions, disease involvement, and biomarker applications are not applicable. **Key points:** - RPL6P28 is not a protein-coding gene; it is a non-functional copy (pseudogene) of the ribosomal protein L6 gene[3][4]. - There is no evidence or recognition of RPL6P28 as a therapeutic target or in drug development[3][4]. - No biological functions, disease associations, or drug interactions are known for RPL6P28[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L6 pseudogene 28 (RPL6P28).